medigraphic.com
SPANISH

Annals of Hepatology

Órgano Oficial de la Asociación Mexicana de Hepatología
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2006, Number 1

<< Back Next >>

Ann Hepatol 2006; 5 (1)

A 57 year old man with chronic renal failure and cardiac tamponade who developed ischemic hepatitis

López-Méndez E, López-Méndez E, López-Méndez I, Hernández-Reyes P, Galindo-Uribe J, Angulo-Ramírez V, Ávila-Escobedo L, Uribe M
Full text How to cite this article

Language: English
References: 8
Page: 50-52
PDF size: 75.89 Kb.


Key words:

Ischemic hepatitis, alanine transferase, aspartate transferase, hepatic encephalopathy.

Text Extraction

Ischemic hepatitis is an infrequent entity, usually associated with low cardiac out put. We present a case of a 57 year-old man with chronic renal failure and cardiac tamponade who developed elevation of serum alanine transferase level of 5,054 U/L, aspartate transferase level of 8,747 U/L and lactate dehydrogenasa level of 15,220 U/L. The patient developed hepatic encephalopathy and hypoglycemia. Liver Doppler ultrasound was normal. He was seronegative for HBV and HCV, drugs list was scrutinized for the names of known hepatotoxins. Ischemic hepatitis was diagnosed. The hypoglycemia and encephalopathy were solved and the patient was discharged with normal transaminase levels. Ischemic hepatitis is typically preceded by hypotension, hypoxemia, or both. As one would expect, the most common cause of sustained systemic hypotension is cardiovascular disease. Liver biopsy is usually not necessary. The best treatment is support measures and correct the underlying condition.


REFERENCES

  1. Johnson RD, O’Connor ML, Kerr RM. Extreme serum elevations of aspartate aminotransferase. Am J Gastroenterol 1995; 90: 1244-5.

  2. Bruguera M, Barrera JM, Corradi F, Mas A. Hypertransaminasemia greater than 400 U/L in adults seen at a tertiary hospital. Prospective study of etiology. Gastroenterol Hepatol 2005; 28: 15-9.

  3. Fuchs S, Bogomolski-Yahalom V, Paltiel O, Ackerman Z. Ischemic hepatitis: clinical and laboratory observations of 34 patients. J Clin Gastroenterol 1998; 26: 183-6.

  4. Seeto RK, Fenn B, Rockey DC. Ischemic hepatitis: clinical presentation and pathogenesis. Am J Med 2000; 109: 109-13.

  5. Trakada G, Gogos C, Tsiamita M, Siagris D, Goumas P, Spiropoulos K. A case of ischemic hepatitis. Sleep Breath 2004; 8: 155-59.

  6. Mathurin P, Durand F, Ganne N, Mollo JL, Lebrec D, Degott C, Erlinger s, et al. Ischemic hepatitis due to obstructive sleep apnea. Gastroenterology 1995; 109: 1682-4.

  7. Henrion J, Colin L, Schapira M. Heller FR. Hypoxic hepatitis caused by severe hypoxemia from obstructive sleep apnea. J Clin Gastroenterol 1997; 24: 245-9.

  8. Henrion J, Schapira M, Luwaert R Colin L, Delannoy A, Heller FR. Hypoxic hepatitis: clinical and hemodynamic study in 142 consecutive cases. Medicine 2003; 82: 392-406.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Ann Hepatol. 2006;5